Trehalose decreases mRNA and protein expressions of c-Jun and JunB in human cervical cancer HeLa cells

J Biochem. 2022 Sep 5;172(3):177-187. doi: 10.1093/jb/mvac051.

Abstract

Increasing evidence suggests that trehalose, a non-reducing disaccharide, ameliorates disease phenotypes by activating autophagy in animal models of various human diseases, including neurodegenerative diseases. Multiple in vitro studies suggest that activation of transcription factor EB, a master regulator of lysosomal biogenesis and autophagy genes, is a major contributor to trehalose-induced autophagy at later stages of exposure. However, underlying causes of trehalose-induced autophagy possibly occur at the early stage of the exposure period. In this study, we investigated the effects of short-term exposure of HeLa cells to trehalose on several signal transduction pathways to elucidate the initial events involved in its beneficial effects. Phospho-protein array analysis revealed that trehalose decreases levels of phosphorylated c-Jun, a component of the transcription factor activator protein-1, after 6 h. Trehalose also rapidly reduced mRNA expression levels of c-Jun and JunB, a member of the Jun family, within 1 h, resulting in a subsequent decrease in their protein levels. Future studies, exploring the interplay between decreased c-Jun and JunB protein levels and beneficial effects of trehalose, may provide novel insights into the mechanisms of trehalose action.

Keywords: JunB; autophagy; c-Jun; cell signaling; trehalose.

MeSH terms

  • Autophagy
  • Female
  • HeLa Cells
  • Humans
  • Proto-Oncogene Proteins c-jun* / genetics
  • Proto-Oncogene Proteins c-jun* / metabolism
  • RNA, Messenger / genetics
  • Transcription Factors* / genetics
  • Transcription Factors* / metabolism
  • Trehalose* / pharmacology
  • Uterine Cervical Neoplasms*

Substances

  • JunB protein, human
  • Proto-Oncogene Proteins c-jun
  • RNA, Messenger
  • Transcription Factors
  • Trehalose